Norgine B.V. announces Senior Management changes: Christopher Bath appointed Chief Executive Officer – Peter Stein to assume role of…
Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today announces that Christopher Bath has been appointed Chief Executive Officer (CEO) effective 1st January 2022. Chris will be responsible for a business with a portfolio of market leading medicinal products with net annual sales of approximately €500 million, a pipeline of innovative product candidates and global operations with direct presence in 12 European markets, Australia and New Zealand. Chris, who is!-->…